A team of researchers led by the University of California San Diego and Stanford University has developed a noninvasive method to monitor the ...

A University of Massachusetts Amherst-Ernest Pharmaceuticals team of scientists has made "exciting," patient-friendly ...

Johnson & Johnson (NYSE: JNJ) is reportedly considering a bid for biopharmaceutical company Intracellular Therapies (NASDAQ: ...

Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) was upgraded by equities research analysts at Cantor Fitzgerald from ...

Most pathogens, especially the food/water/air-borne germs, would have to interact with the mucosal barrier system in order to invade hosts. Intracellular pathogens such as microsporidia, Mycobacterium ...

Fintel reports that on January 14, 2025, Piper Sandler downgraded their outlook for Intra-Cellular Therapies (NasdaqGS:ITCI) ...

A joint research team has developed a biotemplating method that utilizes specific internal proteins in biological samples and ...

Johnson & Johnson said on Monday it would buy drugmaker Intra-Cellular Therapies for about $14.6 billion, boosting its ...

Genetic changes are a significant cause of infertility, impacting over 15% of the global population. TLE6, a major protein ...

You will be redirected to our submission process. Apicomplexan parasites are obligate intracellular protozoans that can cause severe human and animal diseases, such as malaria, toxoplasmosis, ...

Department of Radiology, Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford, California 94305, United States ...